(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 16 720.00 |
Vidutinė apimtis | 8 944.00 |
Rinkos kapitalizacija | 37.99M |
EPS | $0 ( 2024-03-22 ) |
Kita pelno data | ( $0 ) 2024-05-09 |
Last Dividend | $0.100 ( 2023-07-25 ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.77 |
ATR14 | $0.0560 (0.68%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Kolinski Catherine | Buy | 0 | |
2023-06-09 | Vigilante Donna | Sell | 0 | United-Guardian,Inc. Common Stock |
2022-11-01 | Blanco Beatriz | Buy | 0 | |
2022-11-01 | Blanco Beatriz | Buy | 0 | |
2021-02-19 | Globus Kenneth H | Sell | 8 400 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 97 transactions |
Buy: 1 400 | Sell: 81 010 |
United-Guardian Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
INVE | 0.92 |
SVAC | 0.918 |
TSP | 0.896 |
PAIC | 0.895 |
TLGT | 0.884 |
TTGT | 0.878 |
VSTA | 0.876 |
SGRP | 0.874 |
LPTX | 0.872 |
TIL | 0.872 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
NETE | -0.908 |
SRAC | -0.904 |
LWAC | -0.889 |
RAVN | -0.884 |
UFPT | -0.865 |
BILI | -0.842 |
AGFS | -0.828 |
MDLZ | -0.825 |
BSMS | -0.82 |
IMRA | -0.818 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
United-Guardian Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $10.89M |
Bruto pelnas: | $5.41M (49.66 %) |
EPS: | $0.560 |
FY | 2023 |
Pajamos: | $10.89M |
Bruto pelnas: | $5.41M (49.66 %) |
EPS: | $0.560 |
FY | 2022 |
Pajamos: | $12.70M |
Bruto pelnas: | $6.70M (52.78 %) |
EPS: | $0.560 |
FY | 2021 |
Pajamos: | $13.93M |
Bruto pelnas: | $8.18M (58.74 %) |
EPS: | $1.010 |
Financial Reports:
No articles found.
United-Guardian Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.310 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.100 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0600 | 1997-12-10 |
Last Dividend | $0.100 | 2023-07-25 |
Next Dividend | $0 | N/A |
Payout Date | 2023-08-02 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | $15.69 | -- |
Avg. Dividend % Per Year | 2.37% | -- |
Score | 4.92 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.42 | |
Div. Directional Score | 8.39 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $0.0600 | 3.43% |
1998 | $0.0180 | 0.44% |
1999 | $0.0180 | 0.42% |
2000 | $0.100 | 2.67% |
2001 | $0.100 | 2.22% |
2002 | $0.100 | 1.92% |
2003 | $0.150 | 3.64% |
2004 | $0.430 | 5.48% |
2005 | $0.470 | 5.60% |
2006 | $0.470 | 5.25% |
2007 | $0.550 | 6.43% |
2008 | $0.550 | 5.24% |
2009 | $0.600 | 6.64% |
2010 | $0.630 | 5.48% |
2011 | $0.800 | 5.59% |
2012 | $1.360 | 9.07% |
2013 | $0.970 | 4.85% |
2014 | $0.800 | 2.86% |
2015 | $1.000 | 5.14% |
2016 | $0.750 | 3.69% |
2017 | $0.920 | 5.95% |
2018 | $1.050 | 5.79% |
2019 | $1.100 | 5.84% |
2020 | $0.780 | 3.84% |
2021 | $1.130 | 7.77% |
2022 | $0.680 | 4.12% |
2023 | $0.100 | 0.94% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.237 | 1.500 | 5.26 | 7.89 | [0 - 0.5] |
returnOnAssetsTTM | 0.193 | 1.200 | 3.56 | 4.27 | [0 - 0.3] |
returnOnEquityTTM | 0.243 | 1.500 | 8.41 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.178 | -1.000 | 8.22 | -8.22 | [0 - 1] |
currentRatioTTM | 7.99 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.95 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 5.37 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00159 | -1.500 | 9.97 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -23.79 | 1.000 | -9.92 | -9.92 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.684 | 2.00 | 9.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.648 | 2.00 | 9.68 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00187 | -1.500 | 9.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.497 | 1.000 | 5.06 | 5.06 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.263 | 1.000 | 6.74 | 6.74 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 147.87 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.815 | 0.800 | 7.90 | 6.32 | [0.5 - 2] |
Total Score | 11.36 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.72 | 1.000 | 8.61 | 0 | [1 - 100] |
returnOnEquityTTM | 0.243 | 2.50 | 8.98 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.648 | 2.00 | 9.78 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.23 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.684 | 2.00 | 9.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.178 | 1.500 | 8.22 | -8.22 | [0 - 1] |
pegRatioTTM | -0.471 | 1.500 | -6.47 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.289 | 1.000 | 5.28 | 0 | [0.1 - 0.5] |
Total Score | 5.42 |
United-Guardian Inc
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.